Should Vir Biotechnology Inc (VIR) Stock be in Your Portfolio?

Tuesday, June 30, 2020 4:08 PM | InvestorsObserver Analysts

Vir Biotechnology Inc (VIR) stock is higher by 192.23% since Friday, October 11, 2019 when VIR began trading. , and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives VIR stock a score of 12 out of a possible 100.

That rank is primarily influenced by a long-term technical score of 0. VIR's rank also includes a fundamental score of 1. In addition to the average rating from Wall Street analysts, VIR stock has a mean target price of 22.666. This means analysts expect the stock to decrease 44.68% over the next 12 months. The short-term technical score for VIR is 35.

Overall Score - 12
VIR has an Overall Score of 12. Find out what this means to you and get the rest of the rankings on VIR!

What's Happening with VIR Stock Today

Vir Biotechnology Inc (VIR) stock is up 12.8% while the S&P 500 is higher by 0.59% as of 4:00 PM on Tuesday, Jun 30. VIR is higher by $4.65 from the previous closing price of $36.32 on volume of 1,805,543 shares. Over the past year the S&P 500 has risen 3.40% while VIR is higher by 192.23%. VIR lost -$6.21 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Vir Biotechnology Inc (VIR) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

40% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 57% with annual

InvestorsObserver Premium

$ 20.75 $ 12.45 /month
$249 $149.40 billed annually

You May Also Like

Related Articles

TSX Down 21 Points on Mixed Sectors

Sector Update: Consumer Stocks Extending Thursday Advance

Moderna Inc (MRNA) Stock: What's Next?

Related Companies